Mapping of a Minimal Apolipoprotein(a) Interaction Motif Conserved in Fibrin(ogen) β- and γ-Chains*
暂无分享,去创建一个
W. Parson | G. Baier | F. Fresser | G. Utermann | S. Köchl | R. Klose | J. Fruchart‐Najib | A. Kapetanopoulos
[1] C. J. Halfman,et al. The relationship between the effect of lysine analogues and salt on the conformation of lipoprotein(a). , 2000, Biochemistry.
[2] G. Utermann,et al. Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians. , 1999, Human molecular genetics.
[3] H. Hobbs,et al. Lipoprotein(a): intrigues and insights. , 1999, Current opinion in lipidology.
[4] R. Lawn,et al. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. Ugarova,et al. Identification of a Novel Recognition Sequence for Integrin αMβ2 within the γ-chain of Fibrinogen* , 1998, The Journal of Biological Chemistry.
[6] R. Willette,et al. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. , 1998, Circulation research.
[7] P. Harpel,et al. Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells. , 1998, Biochemistry.
[8] J. Morrisett,et al. Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm , 1997, Clinical genetics.
[9] R. Doolittle,et al. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.
[10] G. Baier,et al. Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain. , 1997, Blood.
[11] E. Rubin,et al. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. , 1997, The Journal of clinical investigation.
[12] A. Noma,et al. Immunolocalization of Lipoprotein(a) in Wounded Tissues , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] E. Davie,et al. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .
[14] O. Klezovitch,et al. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes. , 1996, The Journal of clinical investigation.
[15] B. Nordestgaard,et al. Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. , 1996, Circulation research.
[16] J. Eaton,et al. Molecular determinants of acute inflammatory responses to biomaterials. , 1996, The Journal of clinical investigation.
[17] O. Klezovitch,et al. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[18] S. Meredith,et al. Ligand-induced conformational change of lipoprotein(a). , 1996, Biochemistry.
[19] F. Kronenberg,et al. A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. , 1995, The Journal of clinical investigation.
[20] H. Robenek,et al. Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase. , 1995, Journal of lipid research.
[21] V. Armstrong,et al. Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 3236 of Human Apolipoprotein(a) (*) , 1995, The Journal of Biological Chemistry.
[22] L. Curtiss,et al. Interaction of Lp(a) with Plasminogen Binding Sites on Cells , 1995, Thrombosis and Haemostasis.
[23] B. Furie,et al. Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis , 1995, Nature Medicine.
[24] G. Kostner,et al. Structural requirements of apo-a for the lipoprotein-a assembly. , 1994, The Biochemical journal.
[25] J. Lee,et al. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). , 1994, Biochimica et biophysica acta.
[26] K. Zatloukal,et al. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein. , 1994, Biochemistry.
[27] M. Koschinsky,et al. Carboxyl‐terminal truncation of apolipoproteinB‐100 inhibits lipoprotein(a) particle formation , 1994 .
[28] R. Lawn,et al. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice , 1994, Nature.
[29] G. Utermann,et al. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Koschinsky,et al. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. , 1992, Biochemistry.
[31] J. Morrisett,et al. A structural assessment of the apo[a] protein of human lipoprotein[a] , 1992, Proteins.
[32] S. Fields,et al. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Loscalzo,et al. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein. , 1991, Biochemistry.
[34] D. Rifkin,et al. Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration , 1991, The Journal of cell biology.
[35] E. Boerwinkle,et al. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.
[36] D. Rouy,et al. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[37] H. Hoff,et al. Quantification of apo[a] and apoB in human atherosclerotic lesions. , 1991, Journal of lipid research.
[38] M. Koschinsky,et al. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. , 1990, Biochemistry.
[39] J. Breslow,et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.
[40] A. Scanu,et al. A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.
[41] B. Gordon,et al. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[43] G. Utermann,et al. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.
[44] J. Butler,et al. The immunochemistry of sandwich ELISAs. II. A novel system prevents the denaturation of capture antibodies. , 1986, Immunology letters.
[45] R. B. Merrifield,et al. An SN2 deprotection of synthetic peptides with a low concentration of hydrofluoric acid in dimethyl sulfide: evidence and application in peptide synthesis , 1983 .
[46] L. Patthy,et al. Location of plasminogen-binding sites in human fibrin(ogen). , 1983, Biochemistry.
[47] R. Laursen,et al. Studies on the lysine-binding sites of human plasminogen. The effect of ligand structure on the binding of lysine analogs to plasminogen. , 1980, European journal of biochemistry.
[48] Ivan Damjanov,et al. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.
[49] E. Janus,et al. Frequency Distributions of Apolipoprotein(a) Kringle IV Repeat Alleles and Their Effects on Lipoprotein(a) Levels in Caucasian, Asian, and African Populations: The Distribution of Null Alleles Is Non-Random , 1996, European journal of human genetics : EJHG.
[50] E. Angles-cano,et al. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces. , 1994, Chemistry and physics of lipids.
[51] S. Pizzo,et al. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. , 1990, Thrombosis research.